SARAH FISHER: Open Payments
NPI 1588891030 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,119 in 49 payments from 11 companies in 2025. Trend: 2023 $1,304 · 2024 $916 · 2025 $1,119
Food & beverage: $1,020Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $450 |
| Janssen Biotech, Inc. | 7 | $303 |
| Amgen Inc. | 3 | $65 |
| UCB, Inc. | 2 | $64 |
| Mallinckrodt Hospital Products Inc. | 2 | $60 |
| PFIZER INC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| SOBI, INC | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Bimzelx, ACTHAR, XELJANZ, SAPHNELO, SPEVIGO.
Industry payments across MD — which companies pay providers there.
